{"entity":{"type":"insider","cik":"0001285648","url":"/insider/0001285648","json_url":"/insider/0001285648.json","name":"CAUWENBERGH GEERT","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":117,"n_filings":59,"first":"2004-05-06","last":"2017-10-02","span_basis":"filed_date"},"name_variants":[{"name":"CAUWENBERGH GEERT","source":"filing","n_filings":59,"first_seen":"2004-05-06","last_seen":"2017-10-02"}],"transactions":[{"id":4225811,"accession":"0001209191-17-054555","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-054555","line_url":"/filing/0001209191-17-054555","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.4475,"price_display":"0.45","price_state":"stated","total_value":4475.0,"total_display":"4,475.00","total_whole":"4,475","shares_owned_after":142583.0,"shares_owned_after_display":"142,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-02","scope":"insider","n_lines":3},{"id":4447587,"accession":"0001209191-17-050044","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-050044","line_url":"/filing/0001209191-17-050044","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.548289,"price_display":"0.55","price_state":"stated","total_value":5482.89,"total_display":"5,482.89","total_whole":"5,483","shares_owned_after":127483.0,"shares_owned_after_display":"127,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-24","filed_date":"2017-08-24","scope":"insider","n_lines":3},{"id":5351990,"accession":"0001209191-17-041289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-041289","line_url":"/filing/0001209191-17-041289","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.625,"price_display":"0.62","price_state":"stated","total_value":6250.0,"total_display":"6,250.00","total_whole":"6,250","shares_owned_after":117583.0,"shares_owned_after_display":"117,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-22","filed_date":"2017-06-22","scope":"insider","n_lines":2},{"id":4196624,"accession":"0001209191-17-028187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-028187","line_url":"/filing/0001209191-17-028187#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.648,"price_display":"0.65","price_state":"stated","total_value":6480.0,"total_display":"6,480.00","total_whole":"6,480","shares_owned_after":112583.0,"shares_owned_after_display":"112,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-04-26","scope":"insider"},{"id":4829870,"accession":"0001209191-17-021599","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-021599","line_url":"/filing/0001209191-17-021599","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.7692014,"price_display":"0.77","price_state":"stated","total_value":7692.014,"total_display":"7,692.01","total_whole":"7,692","shares_owned_after":101903.0,"shares_owned_after_display":"101,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-20","scope":"insider","n_lines":3},{"id":4933989,"accession":"0001209191-17-012427","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-012427","line_url":"/filing/0001209191-17-012427","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.69314042,"price_display":"0.69","price_state":"stated","total_value":6931.4042,"total_display":"6,931.40","total_whole":"6,931","shares_owned_after":89666.0,"shares_owned_after_display":"89,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-02-21","scope":"insider","n_lines":3},{"id":4828354,"accession":"0001209191-17-008542","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-008542","line_url":"/filing/0001209191-17-008542#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.685,"price_display":"0.68","price_state":"stated","total_value":6850.0,"total_display":"6,850.00","total_whole":"6,850","shares_owned_after":82583.0,"shares_owned_after_display":"82,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-08","filed_date":"2017-02-08","scope":"insider"},{"id":5278122,"accession":"0001209191-17-005642","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-005642","line_url":"/filing/0001209191-17-005642","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.696596,"price_display":"0.70","price_state":"stated","total_value":6965.96,"total_display":"6,965.96","total_whole":"6,966","shares_owned_after":72583.0,"shares_owned_after_display":"72,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-25","filed_date":"2017-01-26","scope":"insider","n_lines":2},{"id":4774611,"accession":"0001209191-17-004383","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-004383","line_url":"/filing/0001209191-17-004383","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.694874,"price_display":"0.69","price_state":"stated","total_value":6948.74,"total_display":"6,948.74","total_whole":"6,949","shares_owned_after":58983.0,"shares_owned_after_display":"58,983","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-19","filed_date":"2017-01-19","scope":"insider","n_lines":3},{"id":8718843,"accession":"0001209191-15-031113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-031113","line_url":"/filing/0001209191-15-031113#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.7192,"price_display":"0.72","price_state":"stated","total_value":3596.0,"total_display":"3,596.00","total_whole":"3,596","shares_owned_after":67500.0,"shares_owned_after_display":"67,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-02","filed_date":"2015-04-02","scope":"insider"},{"id":8920236,"accession":"0001209191-15-015052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-015052","line_url":"/filing/0001209191-15-015052#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":4680.0,"total_display":"4,680.00","total_whole":"4,680","shares_owned_after":62500.0,"shares_owned_after_display":"62,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-18","scope":"insider"},{"id":8899750,"accession":"0001209191-15-011758","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-011758","line_url":"/filing/0001209191-15-011758","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.2437222,"price_display":"1.24","price_state":"stated","total_value":2487.4444,"total_display":"2,487.44","total_whole":"2,487","shares_owned_after":58500.0,"shares_owned_after_display":"58,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-10","filed_date":"2015-02-11","scope":"insider","n_lines":3},{"id":8369165,"accession":"0001209191-15-004882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-004882","line_url":"/filing/0001209191-15-004882#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":10300.0,"total_display":"10,300.00","total_whole":"10,300","shares_owned_after":56500.0,"shares_owned_after_display":"56,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-20","filed_date":"2015-01-20","scope":"insider"},{"id":6594475,"accession":"0001209191-14-078466","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-078466","line_url":"/filing/0001209191-14-078466","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.58722,"price_display":"1.59","price_state":"stated","total_value":3968.05,"total_display":"3,968.05","total_whole":"3,968","shares_owned_after":46000.0,"shares_owned_after_display":"46,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-30","filed_date":"2014-12-31","scope":"insider","n_lines":2},{"id":6992773,"accession":"0001181431-14-034213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-034213","line_url":"/filing/0001181431-14-034213#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.6799,"price_display":"1.68","price_state":"stated","total_value":5039.7,"total_display":"5,039.70","total_whole":"5,040","shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-13","filed_date":"2014-10-14","scope":"insider"},{"id":6585453,"accession":"0001181431-14-032520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-032520","line_url":"/filing/0001181431-14-032520#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":9900.0,"total_display":"9,900.00","total_whole":"9,900","shares_owned_after":4500.0,"shares_owned_after_display":"4,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2014-09-23","scope":"insider"},{"id":7008133,"accession":"0001181431-14-032060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-032060","line_url":"/filing/0001181431-14-032060#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.078,"price_display":"2.08","price_state":"stated","total_value":10390.0,"total_display":"10,390.00","total_whole":"10,390","shares_owned_after":46000.0,"shares_owned_after_display":"46,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-09-16","filed_date":"2014-09-16","scope":"insider"},{"id":6554007,"accession":"0001181431-14-031916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-031916","line_url":"/filing/0001181431-14-031916","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.18492,"price_display":"2.18","price_state":"stated","total_value":21849.2,"total_display":"21,849.20","total_whole":"21,849","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-15","filed_date":"2014-09-15","scope":"insider","n_lines":3},{"id":6408152,"accession":"0001181431-14-026895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-026895","line_url":"/filing/0001181431-14-026895#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":2500.0,"total_display":"2,500.00","total_whole":"2,500","shares_owned_after":31000.0,"shares_owned_after_display":"31,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-15","filed_date":"2014-07-17","scope":"insider"},{"id":6308588,"accession":"0001181431-14-026445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-026445","line_url":"/filing/0001181431-14-026445#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":2.5699,"price_display":"2.57","price_state":"stated","total_value":3597.86,"total_display":"3,597.86","total_whole":"3,598","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-09","filed_date":"2014-07-09","scope":"insider"},{"id":6697698,"accession":"0001181431-14-025698","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-025698","line_url":"/filing/0001181431-14-025698","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.85645,"price_display":"2.86","price_state":"stated","total_value":5712.9,"total_display":"5,712.90","total_whole":"5,713","shares_owned_after":28300.0,"shares_owned_after_display":"28,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-02","filed_date":"2014-07-02","scope":"insider","n_lines":3},{"id":6584967,"accession":"0001181431-14-025043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-025043","line_url":"/filing/0001181431-14-025043#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":3.01,"price_display":"3.01","price_state":"stated","total_value":1505.0,"total_display":"1,505.00","total_whole":"1,505","shares_owned_after":26600.0,"shares_owned_after_display":"26,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-25","filed_date":"2014-06-26","scope":"insider"},{"id":6519744,"accession":"0001181431-14-024489","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-024489","line_url":"/filing/0001181431-14-024489","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.98005,"price_display":"2.98","price_state":"stated","total_value":5960.1,"total_display":"5,960.10","total_whole":"5,960","shares_owned_after":25100.0,"shares_owned_after_display":"25,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-19","filed_date":"2014-06-19","scope":"insider","n_lines":3},{"id":6553640,"accession":"0001181431-14-023239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-023239","line_url":"/filing/0001181431-14-023239","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":3.04992,"price_display":"3.05","price_state":"stated","total_value":3049.92,"total_display":"3,049.92","total_whole":"3,050","shares_owned_after":24100.0,"shares_owned_after_display":"24,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-09","filed_date":"2014-06-09","scope":"insider","n_lines":2},{"id":6553617,"accession":"0001181431-14-022758","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-022758","line_url":"/filing/0001181431-14-022758","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":2.94275,"price_display":"2.94","price_state":"stated","total_value":5885.5,"total_display":"5,885.50","total_whole":"5,886","shares_owned_after":23100.0,"shares_owned_after_display":"23,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-04","filed_date":"2014-06-05","scope":"insider","n_lines":2},{"id":5362612,"accession":"0001181431-13-056063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-056063","line_url":"/filing/0001181431-13-056063#line-2","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":2552.0,"total_display":"2,552.00","total_whole":"2,552","shares_owned_after":21100.0,"shares_owned_after_display":"21,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-31","filed_date":"2013-11-01","scope":"insider"},{"id":5362608,"accession":"0001181431-13-056063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-056063","line_url":"/filing/0001181431-13-056063#line-1","is_derivative":false,"issuer_cik":"0001285648","issuer_name":"RXi Pharmaceuticals Corp","issuer_ticker":"RXII","issuer_name_source":null,"issuer_url":"/issuer/0001285648","owner_cik":"0001285648","owner_name":"CAUWENBERGH GEERT","owner_display_name":"CAUWENBERGH GEERT","owner_url":"/insider/0001285648","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common stock, $0.0001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":618.0,"total_display":"618.00","total_whole":"618","shares_owned_after":20300.0,"shares_owned_after_display":"20,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-30","filed_date":"2013-11-01","scope":"insider"}],"collapsed":true,"next_cursor":"2013-10-30|5362608","ledger_fault":false,"count":{"value":117,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":117,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":117},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533040","name":"RXi Pharmaceuticals Corp","url":"/issuer/0001533040","role":"Director, Officer (President & CEO)","n_filings":53,"first_seen":"2013-07-29","last_seen":"2017-10-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001173657","name":"BARRIER THERAPEUTICS INC","url":"/issuer/0001173657","role":"Director, Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2004-05-06","last_seen":"2006-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001285648","retrieved_at":"2026-08-24T08:51:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}